PureTech News

Press releases
Press Releases - 2022-08-25
PureTech Founded Entity Gelesis Presented Clinical Data from the LIGHT-UP Study at the International Congress of Endocrinology that Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome
Press Releases - 2022-08-25
PureTech Health plc - Half-Year Report
Press Releases - 2022-08-22
PureTech Founded Entity Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I
Press Releases - 2022-08-09
PureTech to Receive up to Approximately $115.4 Million from Sale of a Portion of Founded Entity Shares
Press Releases - 2022-08-08
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia
Press Releases - 2022-08-04
Notice of Half-Yearly Results
Press Releases - 2022-08-01
PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
Press Releases - 2022-07-14
PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate
Press Releases - 2022-07-11
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
Press Releases - 2022-06-30
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)
Displaying 31 - 40 of 342

Sign up for email alerts

To receive news as it is released, please sign up.